Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
C

Cie Industrielle Financiere Entreprise SA
PAR:INFE

Watchlist Manager
Cie Industrielle Financiere Entreprise SA
PAR:INFE
Watchlist
Price: 71 EUR Market Closed
Market Cap: €85.2m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+36%
5Y
+61%
10Y
+74%
Liabilities
+
3Y
+83%
5Y
+144%
10Y
+160%
Equity
+
3Y
-36%
5Y
-36%
10Y
-30%

Balance Sheet Decomposition
Cie Industrielle Financiere Entreprise SA

Balance Sheet
Cie Industrielle Financiere Entreprise SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
3
2
3
39
32
40
46
47
41
25
25
26
30
6
38
42
26
37
29
39
45
65
77
82
Cash
0
0
0
0
0
0
0
10
9
7
15
17
12
6
0
0
15
27
29
39
36
53
48
39
Cash Equivalents
3
2
3
39
32
40
46
37
32
18
11
10
18
0
38
42
11
11
0
0
9
12
29
43
Short-Term Investments
24
27
34
5
5
0
1
5
6
10
23
18
22
0
0
21
26
18
27
22
9
13
3
0
Total Receivables
29
35
36
35
55
60
72
59
52
41
46
53
63
0
0
68
83
81
91
94
93
142
107
123
Accounts Receivables
28
34
35
27
46
53
60
49
41
32
37
44
53
0
0
53
62
59
66
71
76
116
85
96
Other Receivables
1
1
1
8
9
7
12
10
12
10
9
9
10
0
0
16
21
23
25
23
18
26
22
26
Inventory
11
9
7
10
9
9
15
19
13
8
5
9
9
10
7
8
0
0
2
3
10
13
2
2
Other Current Assets
0
0
0
1
1
2
2
1
0
0
0
0
0
0
0
1
0
1
1
2
6
2
5
6
Total Current Assets
67
72
80
89
101
110
136
132
113
85
100
107
124
10
7
141
136
138
151
159
164
234
194
212
PP&E Net
11
10
8
9
10
11
15
16
15
14
16
17
19
0
0
27
26
27
37
36
37
41
37
37
PP&E Gross
11
10
8
0
0
11
15
16
15
14
16
17
0
0
0
0
26
27
0
0
0
0
0
0
Accumulated Depreciation
16
16
16
0
0
13
14
22
24
25
28
31
0
0
0
0
49
51
0
0
0
0
0
0
Intangible Assets
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
0
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
1
1
1
2
2
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
2
1
2
5
5
8
10
8
38
51
36
39
35
0
0
25
24
24
27
29
27
27
5
3
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
2
1
0
1
71
2
Other Assets
0
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
1
1
1
2
2
Total Assets
80
N/A
83
+4%
90
+8%
103
+15%
117
+13%
129
+11%
162
+25%
157
-3%
167
+6%
151
-10%
152
+1%
164
+8%
178
+9%
0
N/A
0
N/A
194
N/A
187
-4%
192
+2%
218
+14%
227
+4%
230
+1%
305
+33%
309
+1%
256
-17%
Liabilities
Accounts Payable
31
35
38
28
35
37
56
42
39
27
26
34
41
0
0
33
39
33
38
47
43
48
56
58
Short-Term Debt
0
0
0
0
0
1
3
4
5
4
6
7
4
0
0
0
1
3
1
1
3
5
0
2
Current Portion of Long-Term Debt
2
1
2
3
2
1
3
1
7
6
2
4
7
0
0
9
2
3
5
14
6
6
6
6
Other Current Liabilities
4
5
6
24
29
31
38
41
37
29
28
27
32
0
0
38
38
51
60
55
60
119
132
103
Total Current Liabilities
37
40
46
56
65
69
100
87
87
66
62
72
83
0
0
80
80
90
104
116
112
178
194
169
Long-Term Debt
1
1
0
2
1
2
2
2
2
2
3
4
5
0
0
6
8
9
15
14
13
17
12
11
Deferred Income Tax
0
0
0
1
2
1
1
1
2
3
4
5
5
0
0
5
3
1
1
2
2
3
3
1
Minority Interest
4
4
3
2
2
3
2
4
4
3
4
4
4
0
0
2
2
2
3
3
4
4
7
4
Other Liabilities
8
8
6
1
1
1
1
1
1
1
1
1
1
0
0
2
2
2
2
3
3
2
37
2
Total Liabilities
50
N/A
53
+6%
56
+5%
61
+10%
71
+17%
75
+6%
105
+40%
95
-10%
96
+1%
74
-23%
74
0%
86
+16%
97
+13%
0
N/A
0
N/A
96
N/A
95
-1%
103
+9%
126
+21%
138
+10%
134
-3%
204
+53%
252
+24%
186
-26%
Equity
Common Stock
7
7
7
7
7
7
6
24
24
24
24
24
24
0
0
24
24
24
24
24
24
24
24
24
Retained Earnings
22
22
26
36
39
47
50
39
47
53
54
54
57
0
0
74
68
64
69
65
72
77
33
46
Additional Paid In Capital
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
30
N/A
30
+0%
34
+14%
42
+23%
46
+8%
54
+18%
56
+5%
63
+11%
71
+13%
77
+8%
78
+2%
78
-1%
81
+4%
0
N/A
0
N/A
98
N/A
92
-6%
88
-4%
93
+5%
89
-4%
96
+8%
101
+6%
57
-44%
70
+23%
Total Liabilities & Equity
80
N/A
83
+4%
90
+8%
103
+15%
117
+13%
129
+11%
162
+25%
157
-3%
167
+6%
151
-10%
152
+1%
164
+8%
178
+9%
0
N/A
0
N/A
194
N/A
187
-4%
192
+2%
218
+14%
227
+4%
230
+1%
305
+33%
309
+1%
256
-17%
Shares Outstanding
Common Shares Outstanding
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
1
1
1
1
1
1
1
1
1

See Also

Summary
INFE intrinsic value, competitors valuation, and company profile.
DCF Valuation
INFE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INFE stock valuation using valuation multiples.
Wall Street Estimates
INFE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INFE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.